Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel S Merseburger

Showing results (71-80 of 323) with videos related to

Pageof 33
Sort By:
Onkologie|March 2, 2011
Retrospective analyses of patient characteristics having predictive impact on survival under everolimusChristoph Seidel, Martin Fenner, Christoph Reuter, et al.
Aktuelle Urologie|May 24, 2023
[Urology 2030: Why it is key to promote digitisation in urology today to maintain medical care in the future - an expert consensus]Johannes Huber, Hendrik Borgmann, Kurt Miller, et al.
Urologia Internationalis|September 19, 2018
Extended Techniques of Minimally Invasive Surgery in the Retroperitoneum: Practice Pattern in German Urology DepartmentsMarie C Hupe, Mario W Kramer, Tomasz Ozimek, et al.
Urology|August 21, 2012
Evaluating the significance of cyclic adenosine monophosphate-mediated signaling in human prostate: a functional and biochemical studyGeorge T Kedia, Stefan Ückert, Hamiyet Polat, et al.
European Urology|January 31, 2012
EAU guidelines on laser technologiesThomas R W Herrmann, Evangelos N Liatsikos, Udo Nagele, et al.
BJU International|March 10, 2007
The meatal mobilization technique for coronal/subcoronal hypospadias repairJoerg Seibold, Angela Boehmer, Andreas Verger, et al.
BMC Urology|September 30, 2008
RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinomaHossein Tezval, Axel S Merseburger, Ira Matuschek, et al.
Aktuelle Urologie|November 21, 2019
[Retrospective SHI (Statutory Health Insurances) real-world study on initial GnRH antagonist and agonist therapy for advanced prostate cancer: prescription patterns and hospital costs in Germany]Marie Christine Hupe, Peter Hammerer, Miriam Ketz, et al.
The Prostate|December 6, 2008
The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathwaysHossein Tezval, Steffanie Jurk, Farahnaz Atschekzei, et al.
Frontiers in Oncology|December 13, 2018
Retrospective Analysis of Patients With Prostate Cancer Initiating GnRH Agonists/Antagonists Therapy Using a German Claims Database: Epidemiological and Patient OutcomesMarie C Hupe, Peter Hammerer, Miriam Ketz, et al.
Pageof 33

Showing results (71-80 of 323) with videos related to

Sort By:
Pageof 33
Onkologie|March 2, 2011
Retrospective analyses of patient characteristics having predictive impact on survival under everolimusChristoph Seidel, Martin Fenner, Christoph Reuter, et al.
Aktuelle Urologie|May 24, 2023
[Urology 2030: Why it is key to promote digitisation in urology today to maintain medical care in the future - an expert consensus]Johannes Huber, Hendrik Borgmann, Kurt Miller, et al.
Urologia Internationalis|September 19, 2018
Extended Techniques of Minimally Invasive Surgery in the Retroperitoneum: Practice Pattern in German Urology DepartmentsMarie C Hupe, Mario W Kramer, Tomasz Ozimek, et al.
Urology|August 21, 2012
Evaluating the significance of cyclic adenosine monophosphate-mediated signaling in human prostate: a functional and biochemical studyGeorge T Kedia, Stefan Ückert, Hamiyet Polat, et al.
European Urology|January 31, 2012
EAU guidelines on laser technologiesThomas R W Herrmann, Evangelos N Liatsikos, Udo Nagele, et al.
BJU International|March 10, 2007
The meatal mobilization technique for coronal/subcoronal hypospadias repairJoerg Seibold, Angela Boehmer, Andreas Verger, et al.
BMC Urology|September 30, 2008
RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinomaHossein Tezval, Axel S Merseburger, Ira Matuschek, et al.
Aktuelle Urologie|November 21, 2019
[Retrospective SHI (Statutory Health Insurances) real-world study on initial GnRH antagonist and agonist therapy for advanced prostate cancer: prescription patterns and hospital costs in Germany]Marie Christine Hupe, Peter Hammerer, Miriam Ketz, et al.
The Prostate|December 6, 2008
The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathwaysHossein Tezval, Steffanie Jurk, Farahnaz Atschekzei, et al.
Frontiers in Oncology|December 13, 2018
Retrospective Analysis of Patients With Prostate Cancer Initiating GnRH Agonists/Antagonists Therapy Using a German Claims Database: Epidemiological and Patient OutcomesMarie C Hupe, Peter Hammerer, Miriam Ketz, et al.
Pageof 33